NAVICULA-CENTRUM
- Address
- ul. Krzysztofa Cedry, 2, 91-129 Lodz, Poland
NAVICULA-CENTRUM - Autism Spectrum Disorders Research Center
NAVICULA-CENTRUM is a specialized medical research facility dedicated to advancing the understanding and treatment of neurodevelopmental disorders in pediatric and adolescent populations. The center focuses on innovative therapeutic interventions aimed at addressing core symptoms and improving quality of life for children and their families.
- Autism spectrum disorders (ASD) treatment research focusing on social communication and interaction deficits
- Pharmacological intervention studies evaluating novel compounds for neurodevelopmental conditions
- Pediatric and adolescent clinical trial expertise with emphasis on safety and efficacy assessments
The center conducts rigorous multicenter, randomized, double-blind, placebo-controlled trials to evaluate emerging therapeutic options for autism spectrum disorders. Research initiatives utilize validated assessment tools such as the Social Responsiveness Scale (SRS-2) to measure treatment effects on core ASD symptoms, particularly targeting improvements in social communication and interaction deficits. NAVICULA-CENTRUM's commitment to exploring novel pharmacological approaches positions it at the forefront of pediatric neurodevelopmental disorder research.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in NAVICULA-CENTRUM
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Pitolisant Efficacy and Safety in Pediatric Autism Spectrum Disorders: A Randomized, Double-Blind, Placebo-Controlled Multicenter Study | Bioprojet Pharma | Phase II | Not Recruiting | Oct 2023 | Nov 2025 |
IMP list
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Pitolisant | 1 | Unknown | 2023-10-10 | 2023-10-10 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.